Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest autoimmune diseases Stories

2014-03-21 12:22:51

CANTERBURY, England, March 21, 2014 /PRNewswire/ -- - Phase 2b data demonstrates a 60% reduction in pruritus in psoriatic patients treated with CT327 - Data analysis also published in the Journal of the American Academy of Dermatology - Phase 2b CT327 topline data in patients with Atopic Dermatitis and Pruritus due in mid-2014 Creabilis Ltd, the dermatology company with the most advanced targeted topical...

2014-03-20 12:32:58

LFA-REAL(TM) System is first of its kind tool to bring patients deeply into the development process WASHINGTON, March 20, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America announced today that it is funding and leading the development of a first-of-its-kind tool to monitor lupus disease activity called the LFA-REAL((TM))(Rapid Evaluation of Activity in Lupus) System. LFA-REAL will address major challenges in lupus treatment and disease management, and has the potential...

2014-03-20 08:29:06

NORTH CHICAGO, Ill., March 20, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the initiation of a pivotal Phase 3 clinical trial that will evaluate the use of HUMIRA® (adalimumab) as a treatment for fingernail psoriasis in patients with moderate to severe chronic plaque psoriasis, an area of unmet need. Currently there are no approved treatments for fingernail psoriasis. "Since treatment options are limited, we welcome research that evaluates new options for patients suffering...

2014-03-18 23:02:43

Discounted research study “PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022” elaborated by GlobalData is now available at MarketPublishers.com. According to the report, new product launches are set to fuel SLE and LN treatment markets expansion through to 2022. London, UK (PRWEB) March 18, 2014 The systemic Lupus Erythematosus (SLE) treatment market in the 7 major nations (the US, Germany, France, the UK, Italy, Japan,...

2014-03-18 16:25:03

Cloud-based training collaboration delivers clinically relevant information anywhere. CONSHOHOCKEN, Pa., March 18, 2014 /PRNewswire/ -- The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and ePharmaSolutions, a leading clinical services and eClinical solutions provider, today announced their partnership to build and deliver online learning courses to clinicians working in psoriasis (PsO) and psoriatic arthritis (PsA) research and development. Via...

2014-03-18 12:31:24

Patients Rapidly Shifting to New Oral Therapies PHILADELPHIA, March 18, 2014 /PRNewswire/ -- Health Union, LLC announced today on its website http://multiplesclerosis.net the topline results from its "2014 MS in America" survey of over 5,000 multiple sclerosis (MS) patients. This survey is one of the largest of its kind ever conducted. Symptoms - Diagnosis - Treatment Gap Even though scientific evidence[i] shows that early treatment can reduce the risk of disease progression,...

2014-03-13 23:27:41

On Saturday March 22, 2014 Dr. Mercante and his AlignLife staff will be opening their doors to the public for an exciting open house for the entire family. Summerville, SC (PRWEB) March 13, 2014 Someone may not have any gastro intestinal problems such as constipation and/or diarrhea, gas or bloating but could still have celiac disease or gluten sensitivity causing numerous unrelated symptoms affecting mood, energy and overall health. Many people suffer from chronic joint pain,...

Crohn's Disease Associated With Microbiome Imbalance In The Gut
2014-03-13 05:18:52

Lee Rannals for redOrbit.com - Your Universe Online Researchers writing in the journal Cell Host & Microbe say they have found how the intestinal microbial population of newly diagnosed Crohn’s disease patients is different from other individuals. The team says that Crohn’s patients showed increased levels of harmful bacteria and reduced levels of the beneficial bacteria usually found in a healthy gastrointestinal tract. The research included data from the RISK Stratification...

2014-03-12 23:01:43

TriDerma’s Facial Redness Repair™ and Psoriasis Control™ Products are now available at Target stores throughout California. Safe and effective relief for psoriasis and rosacea sufferers without harmful drugs. ANAHEIM, CA (PRWEB) March 12, 2014 TriDerma, a leading provider in medical strength skin care products based in Anaheim, California, is pleased to announce its Facial Redness Repair™ and Psoriasis Control™ Skin Healing Creams are now available in California Target stores....

2014-03-12 08:30:38

The Jeffrey Epstein VI Foundation funds groundbreaking research to prevent Crohns and Colitis Disease. NEW YORK, March 12, 2014 /PRNewswire/ -- Crohns and Colitis Disease is a chronic disease of the lower intestinal track, causing inflammation and a host of crippling symptoms from ulcers to intestinal rupture. The disease affects approximately 700,000 Americans and many more suffer from undiagnosed irritable bowel syndrome. To date, not much is known about the ultimate cause of...